Skandinaviska Enskilda Banken (SEB)
WST icon

Skandinaviska Enskilda Banken (SEB)’s West Pharmaceutical WST Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,232
Closed -$3.64M – 706
2025
Q4 		$3.64M Sell
13,232
-262
-2% -$71.7K 0.01% 473
2025
Q3 		$3.54M Sell
13,494
-839
-6% -$204K 0.01% 476
2025
Q2 		$3.14M Hold
14,333
– – 0.01% 508
2025
Q1 		$3.21M Hold
14,333
– – 0.02% 501
2024
Q4 		$4.71M Sell
14,333
-596
-4% -$188K 0.02% 423
2024
Q3 		$4.48M Sell
14,929
-700
-4% -$214K 0.02% 431
2024
Q2 		$5.15M Buy
15,629
+1,401
+10% +$495K 0.02% 370
2024
Q1 		$5.63M Sell
14,228
-1,145
-7% -$424K 0.03% 379
2023
Q4 		$5.41M Sell
15,373
-21,786
-59% -$7.71M 0.03% 370
2023
Q3 		$13.9M Buy
37,159
+23,207
+166% +$8.97M 0.09% 201
2023
Q2 		$5.34M Buy
13,952
+1,477
+12% +$528K 0.04% 375
2023
Q1 		$4.32M Sell
12,475
-123
-1% -$35.9K 0.03% 390
2022
Q4 		$2.96M Buy
12,598
+841
+7% +$199K 0.02% 454
2022
Q3 		$2.89M Buy
11,757
+310
+3% +$94.4K 0.02% 463
2022
Q2 		$3.46M Sell
11,447
-1,079
-9% -$351K 0.03% 437
2022
Q1 		$5.14M Sell
12,526
-1,862
-13% -$729K 0.03% 386
2021
Q4 		$6.78M Buy
14,388
+1,025
+8% +$441K 0.03% 361
2021
Q3 		$5.67M Sell
13,363
-65,661
-83% -$27.7M 0.03% 388
2021
Q2 		$28.4M Sell
79,024
-829
-1% -$274K 0.17% 128
2021
Q1 		$22.5M Sell
79,853
-89,678
-53% -$25.7M 0.15% 142
2020
Q4 		$48M Sell
169,531
-17,097
-9% -$4.8M 0.33% 74
2020
Q3 		$51.3M Buy
186,628
+9,688
+5% +$2.56M 0.38% 62
2020
Q2 		$40.2M Buy
176,940
+131,800
+292% +$25.9M 0.32% 68
2020
Q1 		$6.87M Buy
45,140
+34,787
+336% +$5.35M 0.07% 238
2019
Q4 		$1.56M Buy
+10,353
New +$1.51M 0.01% 621

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s WST Position: Q1 2026 in Review

Skandinaviska Enskilda Banken (SEB) sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 13,232 shares — an estimated $3.64M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in WST in Q4 2019 and held it in 25 quarters. The position peaked at $51.3M in Q3 2020. 755 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 13,232 West Pharmaceutical shares in Q1 2026, an estimated $3.64M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in West Pharmaceutical in Q4 2019 and held it in 25 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s West Pharmaceutical position peaked at $51.3M in Q3 2020.
  • 755 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2026, filed 15 May 2026.